Discontinuation, regain, and reinitiation (class-level, semaglutide / tirzepatide) Budini 2026 ( eClinicalMedicine ) pooled regain curve: asymptotic maximum regain 75.3% of lost weight, half-life about 23 weeks, so roughly 60% of the loss returns by 12 months and about 40% is still held at a year
None of them addresses the actual claim being sold to biohackers, health conscious individuals or athletes which is that BPC-157 enhances recovery, repair, or longevity in healthy people
Researchers have not identified a lethal dose even at concentrations far exceeding therapeutic ranges
What to Expect in Months 4-6 Minimal side effects: 85%+ patients report little to no symptoms Fastest weight loss period: Average loss 15-18% by week 24 Appetite suppression as primary effect: Not unpleasant, just not hungry Metabolic improvements: Blood pressure drops, triglycerides down 28%, A1C down 1.8% in diabetics Increased confidence and motivation: Visible results, compliments from others, clothes fitting differently Data from Diabetes Care journal shows this acceleration phase is when cardiovascular benefits become measurable, blood pressure improvements, lipid improvements, reduced inflammation markers
Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Roliski J
